Home > Insider Trading > Filing (0001077183-19-000058)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1621453	J. Robert Shovlin	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	President, Clinical Services	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-05-02	66,666	$7.15	214,987	No	4	M	Direct
Common Stock	Acquisiton	2019-05-02	66,667	$7.52	281,654	No	4	M	Direct
Common Stock	Disposition	2019-05-02	52,680	$22.14	228,974	No	4	S	Direct
Common Stock	Disposition	2019-05-02	66,667	$22.14	162,307	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-05-02	66,666	$0.00	66,666	$7.15
Common Stock	Stock Option (Right to Buy)	Disposition	2019-05-02	66,667	$0.00	66,667	$7.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-04-20	2021-04-20	No	4	M	Direct
66,667	2018-04-28	2022-04-28	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$8.03	2019-02-26	2023-02-26	288,500	288,500	Direct
Common Stock	Stock Option (Right to Buy)	$19.60	2020-03-01	2024-03-01	66,897	66,897	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-02-26	288,500	288,500	Direct
2024-03-01	66,897	66,897	Direct

Footnotes

On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Mr. Shovlin was granted an option to purchase 66,897 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.